Neural grafting in Parkinson's disease Problems and possibilities (Q37796027)

23 August 2017

title

Neural grafting in Parkinson's disease Problems and possibilities (English)

1 reference

23 August 2017

1 reference

3

Malin Parmar

1 reference

23 August 2017

1

Patrik Brundin

1 reference

23 August 2017

2

Roger A Barker

1 reference

23 August 2017

publication date

1 January 2010

1 reference

Progress in Brain Research

23 August 2017

published in

1 reference

23 August 2017

volume

184

1 reference

23 August 2017

page(s)

265-294

1 reference

A unified hypothesis on the lineage of neural stem cells.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Identification of intrinsic determinants of midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The biology and behaviour of intracerebral adrenal transplants in animals and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Immune problems in central nervous system cell therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neural transplantation for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Stages in the development of Parkinson's disease-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Research in motion: the enigma of Parkinson's disease pathology spread

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Prion-like transmission of protein aggregates in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Karyotype of human ES cells during extended culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Growth factors regulate the survival and fate of cells derived from human neurospheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Large stem cell grafts could lead to erroneous interpretations of behavioral results?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Lewy body pathology in fetal grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Niche-independent symmetrical self-renewal of a mammalian tissue stem cell

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Early morning off-medication dyskinesias, dystonia, and choreic subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Establishment in culture of pluripotential cells from mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The heterogeneity of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Mammalian neural stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Fetal brain transplantation for Parkinson's disease: technique for obtaining donor tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dyskinesias following neural transplantation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopamine neuron precursors within the developing human mesencephalon show radial glial characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

GDNF in Parkinson disease: an object lesson in the tyranny of type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neurogenesis in embryos and in adult neural stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The search for a curative cell therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Modern therapeutic approaches in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Critical issues of clinical human embryonic stem cell therapy for brain repair

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Genomic alterations in cultured human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

GDNF in Parkinson's disease: the perils of post-hoc power

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical con

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Organization of the human embryonic ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

A method for single-cell sorting and expansion of genetically modified human embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Naive and primed pluripotent states

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The promise of human induced pluripotent stem cells for research and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Generation of mouse-induced pluripotent stem cells with plasmid vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopaminergic transplantation for Parkinson's disease: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Regional specification of rodent and human neurospheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Efficient generation of dopamine neurons from human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Regional specification of neurosphere cultures derived from subregions of the embryonic telencephalon

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Derivation of midbrain dopamine neurons from human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Fetal neural graft survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neural progenitors from human embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The morphological development of neurons derived from EGF- and FGF-2-driven human CNS precursors depends on their site of integration in the neonatal rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Chromosome 7 and 19 trisomy in cultured human neural progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The cellular repair of the brain in Parkinson's disease--past, present and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Mifepristone: ten years later

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Induced pluripotent stem cells generated without viral integration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

New cell lines from mouse epiblast share defining features with human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Embryonic stem cell lines derived from human blastocysts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Good manufacturing practice and clinical-grade human embryonic stem cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Direct conversion of fibroblasts to functional neurons by defined factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

NIH neural transplantation funding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Dopaminergic differentiation of human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Triggering endogenous neuroprotective mechanisms in Parkinson's disease: studies with a cellular model.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984014-2

7 January 2021

10.1016/S0079-6123(10)84014-2

Identifiers

DOI

1 reference

23 August 2017

1 reference